← Open Payments lookup

LUZMILA VIA: Open Payments

NPI 1740979251 · RIDGEWAY, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$415 in 23 payments from 12 companies in 2025. Trend: 2023 $45 · 2024 $265 · 2025 $415

Food & beverage: $415
CompanyPaymentsAmount
Novo Nordisk Inc4$73
AstraZeneca Pharmaceuticals LP4$68
ANI Pharmaceuticals, Inc.2$44
Bayer Healthcare Pharmaceuticals Inc.2$38
Ardelyx, Inc.2$37
Gilead Sciences, Inc.2$36
Travere Therapeutics, Inc.2$22
ABBVIE INC.1$21
Dexcom, Inc.1$21
Otsuka America Pharmaceutical, Inc.1$19

Products named: PURIFIED CORTROPHIN GEL, FARXIGA, Kerendia, IBSRELA, Ozempic, QULIPTA, Dexcom G6 Transmitter, VOYXACT.

Industry payments across VA — which companies pay providers there.